{
  "case_id": "case_0049",
  "provider": "openai",
  "status": "processed",
  "patient_demographics": {
    "age": 27.79,
    "sex": "Male",
    "genderIdentity": "Transgender Male",
    "ancestry": "Oceanian"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\nAgree with lesion involving:\n- left optic nerve.\n  \nSome more precision is possible than: 'left thoracic spinal cord'.  \nNamely, in the region of: left T8 spinal cord.",
      "structured_data": {
        "gt_lesions_english": [
          "left T8 myelopathy",
          "left optic nerve (cranial nerve II)"
        ],
        "ft_lesions_parsed": [
          {
            "location": "optic nerve",
            "side": "left",
            "qualifier": null
          },
          {
            "location": "thoracic spinal cord",
            "side": "left",
            "qualifier": null
          }
        ],
        "exact_matches": [
          "left optic nerve (cranial nerve II)"
        ],
        "imprecise_matches": [
          [
            "left thoracic spinal cord",
            [
              "left T8 myelopathy"
            ]
          ]
        ],
        "missing_lesions_from_ft": [],
        "additional_lesions_in_ft": []
      },
      "scoring": {
        "gt_lesion_count": 2,
        "correctly_identified_count": 1,
        "imprecisely_identified_count": 1,
        "missed_lesion_count": 0,
        "additional_lesion_count": 0,
        "proportion_correct": 0.5,
        "proportion_imprecise": 0.5,
        "proportion_missed": 0.0,
        "proportion_additional": 0.0
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included Multiple sclerosis.\n\nAgree to also consider:\n- NMOSD (AQP4+), MOGAD, Neurosarcoid, SLE, Neurosyphilis, Sjogren's and Lyme.\n\nOther possible differentials:\n- Feasible but of low probability: TB, Vasculitis, ADEM, Beh\u00e7et's and Lymphoma.\n\nThe following suggested diagnoses have a low probability of providing a unifying explanation for the full clinical presentation:\n- Compressive thoracic myelopathy with unrelated optic neuropathy (e.g., tumour, disc, dural arteriovenous fistula) (plausible for unilateral spinal cord; but atypical for unilateral optic nerve involvement)\n- Subacute combined degeneration of the cord due to vitamin B12 deficiency (atypical for strictly unilateral optic nerve and strictly unilateral spinal cord involvement)",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Relapsing\u2013remitting multiple sclerosis",
          "Neuromyelitis optica spectrum disorder (AQP4-IgG associated)",
          "Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)",
          "Inflammatory or granulomatous myelitis and optic neuropathy due to neurosarcoidosis",
          "Compressive thoracic myelopathy with unrelated optic neuropathy (e.g., tumour, disc, dural arteriovenous fistula)",
          "Subacute combined degeneration of the cord due to vitamin B12 deficiency",
          "Systemic autoimmune disease with CNS involvement (e.g., systemic lupus erythematosus, vasculitis, Sj\u00f6gren syndrome)",
          "Infectious myelitis or optic neuropathy (e.g., syphilis, HIV, Lyme disease)"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation"
        },
        "correctly_mentioned_original_gt": [
          "Multiple sclerosis"
        ],
        "missing_original_gt": [],
        "matched_lesion_dx_keys": [
          "MOGAD",
          "Syphilis",
          "AQP4_NMOSD",
          "Neurosarcoidosis",
          "Autoimmune_Myelitis_Sjogren",
          "MS",
          "Autoimmune_Myelitis_SLE",
          "Infection_Lyme"
        ],
        "missing_lesion_dx_keys": [
          "CNS_Tuberculosis",
          "CNS_Vasculitis",
          "ADEM",
          "Behcet_Disease",
          "CNS_Lymphoma"
        ],
        "missing_common_names": [],
        "missing_low_prob_names": [
          "TB",
          "Vasculitis",
          "ADEM",
          "Beh\u00e7et's",
          "Lymphoma"
        ],
        "additional_diagnoses": [
          "Compressive thoracic myelopathy with unrelated optic neuropathy (e.g., tumour, disc, dural arteriovenous fistula)",
          "Subacute combined degeneration of the cord due to vitamin B12 deficiency"
        ]
      },
      "scoring": {
        "primary_diagnosis_included": 1,
        "primary_diagnosis_name": "Multiple sclerosis",
        "gt_total_count": 1,
        "gt_matched_count": 1,
        "gt_missed_count": 0,
        "gt_coverage_percentage": 1.0,
        "additional_less_plausible_count": 2,
        "comorbidity_missing_count": 0,
        "other_considerations_missed_count": 0,
        "lesion_ddx_total_count": 13,
        "lesion_ddx_matched_count": 8,
        "lesion_ddx_missed_common_count": 0,
        "lesion_ddx_missed_low_prob_count": 5,
        "lesion_ddx_coverage_percentage": 0.6153846153846154
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\n\n- Agree with the suggested MRI including the Cervical Spine, Brain, Thoracic Spine and Orbits and CSF test for Oligoclonal Bands - would potentially inform a diagnosis/details of multiple sclerosis.\n\nTo evaluate other differential diagnoses:\n- Agree with considering: anti-dsDNA, anti-MOG, ANA, CRP, ENA, ACE, ANCA, HIV, anti-AQP4, syphilis, ESR.\n- Could also consider testing: TB, lyme, CSF (flow cytometry and cytology).",
      "structured_data": {
        "gt_required_tests_primary": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Cervical Spine",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Thoracic Spine",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "MRI of brain and whole spinal cord with gadolinium contrast",
          "Dedicated MRI orbits with fat suppression and gadolinium",
          "Lumbar puncture with CSF cell count, protein, glucose, oligoclonal bands and IgG index",
          "Visual evoked potentials",
          "Optical coherence tomography of retinal nerve fibre layer",
          "Automated visual field testing",
          "Somatosensory evoked potentials of lower limbs",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "C-reactive protein",
          "Erythrocyte sedimentation rate",
          "Blood glucose",
          "Vitamin B12 level",
          "Serum folate level",
          "Thyroid function tests",
          "Serum aquaporin-4 IgG antibody",
          "Serum MOG IgG antibody",
          "Antinuclear antibody",
          "Extractable nuclear antigen panel",
          "Double-stranded DNA antibody",
          "Antineutrophil cytoplasmic antibodies",
          "HIV serology",
          "Syphilis serology (VDRL/TPHA)",
          "Serum angiotensin-converting enzyme level",
          "Serum copper level",
          "Serum protein electrophoresis and immunofixation",
          "Screening for hepatitis B and C",
          "Chest X-ray",
          "Urinalysis"
        ],
        "all_identified_ft_keys": [
          "Anti_dsDNA",
          "MOG_Antibodies",
          "CRP",
          "TFT",
          "Hepatitis_Screen",
          "ENA_Panel",
          "MRI_Orbits",
          "LFT",
          "Vitamin_B12",
          "SSEP",
          "Serum_ACE",
          "Glucose_HbA1c",
          "CSF_Oligoclonal_Bands",
          "U_and_E",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "CSF_General",
          "FBC",
          "ANA",
          "MRI_Whole_Spine",
          "Serum_Copper",
          "OCT",
          "Serum_Protein_Electrophoresis",
          "MRI_Lumbosacral_Spine",
          "MRI_Cervical_Spine",
          "Chest_XRay",
          "Folate",
          "MRI_Thoracic_Spine",
          "Urinalysis",
          "ANCA",
          "HIV_Test",
          "Serum_Immunoglobulins",
          "VEP",
          "MRI_Brain",
          "ESR",
          "Automated_Visual_Fields"
        ],
        "found_tests_primary": [
          {
            "type": "MRI",
            "region": "Cervical Spine",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Thoracic Spine",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests_primary": [],
        "expected_inv_keys_ddx": [
          "Anti_dsDNA",
          "MOG_Antibodies",
          "ANA",
          "CRP",
          "CSF_Flow_Cytometry",
          "TB_Screen",
          "ENA_Panel",
          "Serum_ACE",
          "HIV_Test",
          "ANCA",
          "CSF_Cytology",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "ESR",
          "Lyme_Serology"
        ],
        "found_inv_keys_ddx": [
          "Anti_dsDNA",
          "MOG_Antibodies",
          "ANA",
          "CRP",
          "ENA_Panel",
          "Serum_ACE",
          "ANCA",
          "HIV_Test",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "ESR"
        ],
        "missing_inv_keys_ddx": [
          "CSF_Flow_Cytometry",
          "TB_Screen",
          "CSF_Cytology",
          "Lyme_Serology"
        ]
      },
      "scoring": {
        "primary_tests_required_count": 5,
        "primary_tests_found_count": 5,
        "primary_tests_missed_count": 0,
        "primary_tests_coverage_percentage": 1.0,
        "ddx_tests_expected_count": 15,
        "ddx_tests_found_count": 11,
        "ddx_tests_coverage_percentage": 0.7333333333333333
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Not appropriate to start treatment immediately.\n  \nAdditional factors not mentioned:\n\n- Presenting complaint not specified, so no indication whether this is a new or an old deficit.\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n\nDMTs: Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "Intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Start Now",
            "reasons": [
              "Standard first-line therapy for acute optic neuritis and myelitis due to suspected inflammatory demyelination",
              "Can accelerate neurological and visual recovery and may limit permanent cord and optic nerve damage",
              "Benefits of early treatment outweigh risks in a young otherwise healthy patient once sepsis is excluded"
            ]
          },
          {
            "treatment": "Oral prednisolone taper for 1\u20132 weeks following intravenous steroids",
            "timing": "Delay",
            "reasons": [
              "Used after completion of IV methylprednisolone to reduce risk of rebound relapse and allow gradual steroid withdrawal",
              "Should be tailored to response and contraindications after initial IV course"
            ]
          },
          {
            "treatment": "Initiation of disease-modifying therapy for multiple sclerosis (high-efficacy agent tailored to risk profile if MS confirmed)",
            "timing": "Delay",
            "reasons": [
              "Requires confirmation of MS by McDonald criteria and exclusion of NMOSD/MOGAD and other mimics",
              "Choice of agent depends on MRI lesion burden, relapse severity, comorbidities and serological status (e.g., JCV, hepatitis)",
              "Best initiated in a planned manner in a specialist MS clinic once diagnostic workup is complete"
            ]
          },
          {
            "treatment": "Long-term immunosuppression with agents such as rituximab, mycophenolate mofetil or azathioprine if NMOSD or MOGAD confirmed",
            "timing": "Delay",
            "reasons": [
              "Type and intensity of maintenance therapy depend on antibody status and diagnostic confirmation",
              "These agents carry significant infectious and haematological risks and should not be started before definitive diagnosis",
              "Regimens should be individualised and commenced under specialist neuroimmunology supervision"
            ]
          },
          {
            "treatment": "Plasma exchange",
            "timing": "Delay",
            "reasons": [
              "Reserved for severe optic neuritis or myelitis with poor response to initial high-dose steroids",
              "Invasive therapy requiring vascular access and haemodynamic monitoring, so decision should follow assessment of steroid response over several days"
            ]
          },
          {
            "treatment": "Physiotherapy, gait and balance rehabilitation",
            "timing": "Start Now",
            "reasons": [
              "Addresses left leg weakness, spasticity and unsteady gait to reduce fall risk and promote functional recovery",
              "Early mobilisation helps prevent deconditioning, contractures and venous thromboembolism"
            ]
          },
          {
            "treatment": "Spasticity management (e.g., oral baclofen or tizanidine, stretching programme)",
            "timing": "Start Now",
            "reasons": [
              "Left lower limb spasticity with clonus is already functionally significant and may worsen mobility and cause pain",
              "Early pharmacological and physical measures can improve comfort and gait while limiting long-term contractures"
            ]
          },
          {
            "treatment": "Proton pump inhibitor for gastric protection during high-dose steroid therapy",
            "timing": "Start Now",
            "reasons": [
              "High-dose corticosteroids increase risk of gastrointestinal irritation and ulceration",
              "Simple prophylaxis with PPI reduces steroid-related gastric complications, especially in stressed or hospitalised patients"
            ]
          },
          {
            "treatment": "Thromboprophylaxis with low molecular weight heparin and mechanical compression while inpatient and mobility is reduced",
            "timing": "Start Now",
            "reasons": [
              "Spastic paraparesis and reduced mobility increase venous thromboembolism risk",
              "Hospitalisation and high-dose steroids further augment this risk, so standard prophylaxis is indicated unless contraindicated"
            ]
          },
          {
            "treatment": "Vitamin D supplementation and lifestyle modification (e.g., smoking cessation, exercise programme)",
            "timing": "Delay",
            "reasons": [
              "Adjunctive strategies that may favourably influence long-term MS disease activity if MS is confirmed",
              "Can be initiated after baseline laboratory assessment including calcium and vitamin D levels"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "Intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Start Now",
            "reasons": [
              "Standard first-line therapy for acute optic neuritis and myelitis due to suspected inflammatory demyelination",
              "Can accelerate neurological and visual recovery and may limit permanent cord and optic nerve damage",
              "Benefits of early treatment outweigh risks in a young otherwise healthy patient once sepsis is excluded"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Presenting complaint not specified, so no indication whether this is a new or an old deficit.",
                "Safety screen for contraindications like active infection is required before immunosuppression.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Not appropriate to start treatment immediately.\n  \nAdditional factors not mentioned:\n\n- Presenting complaint not specified, so no indication whether this is a new or an old deficit.\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "Initiation of disease-modifying therapy for multiple sclerosis (high-efficacy agent tailored to risk profile if MS confirmed)",
            "timing": "Delay",
            "reasons": [
              "Requires confirmation of MS by McDonald criteria and exclusion of NMOSD/MOGAD and other mimics",
              "Choice of agent depends on MRI lesion burden, relapse severity, comorbidities and serological status (e.g., JCV, hepatitis)",
              "Best initiated in a planned manner in a specialist MS clinic once diagnostic workup is complete"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis.",
                "Safety screen for contraindications like active infection is required before immunosuppression.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        }
      },
      "scoring": {
        "steroids": {
          "decision_category": "inappropriate_commission",
          "is_unsafe": 1,
          "reasons_total": 3,
          "reasons_acknowledged": 0,
          "reasons_missed": 3,
          "reasons_coverage_percentage": 0.0
        },
        "dmt": {
          "decision_category": "appropriate_caution",
          "is_unsafe": 0,
          "reasons_total": 3,
          "reasons_acknowledged": 1,
          "reasons_missed": 2,
          "reasons_coverage_percentage": 0.3333333333333333
        }
      }
    }
  }
}